The U.S. Dialysis Market is expected to reach USD 73.78 billion by 2030

The increasing prevalence of Chronic Kidney Disease (CKD) will propel the dialysis market during the forecast period.

The U.S. Dialysis Market is valued at USD 58.78 billion in 2023, and is expected to reach USD 73.78 billion by 2030, with a CAGR of 3.3% from 2024 to 2030, according to new research by Next Move Strategy Consulting.

The increasing prevalence of Chronic Kidney Disease (CKD) acts as a significant catalyst for the expansion of the dialysis market. CKD, characterized by a gradual decline in kidney function, is on the rise due to factors such as aging populations, lifestyle-related conditions, and improved awareness leading to early detection.

With the growing occurrence of CKD, there is a parallel uptick in the demand for dialysis services, encompassing both haemodialysis and peritoneal dialysis. This heightened demand places the dialysis market at the forefront of addressing the healthcare requirements of individuals facing CKD, propelling market growth and fostering technological advancements to meet the increasing need for treatment.

Moreover, advancements in healthcare technology are driving significant growth in the U.S. dialysis market. These innovations, such as user-friendly home haemodialysis machines with remote monitoring capabilities, are extending life expectancy for a broader demographic living with chronic conditions. Companies such as Signify Health, a CVS Health subsidiary, are introducing comprehensive in-home assessments for kidney health.

These screenings, provided as part of their In-home Health Evaluation, aim to identify and diagnose kidney issues early, offering convenience and cost savings for individuals under Medicare Advantage coverage. This reflects a positive shift towards more accessible and proactive patient care.

However, the inherent risk of infections and complications associated with these procedures restrains the market.  On the contrary, the introduction of at-home dialysis solutions is creating growth opportunity for the market, where patients can conveniently use dialysis solutions at home.

This approach enhances patient comfort, reduces the need for frequent hospital visits, and provides a flexible kidney care option. As more individuals prefer the convenience of managing their dialysis in the comfort of their homes, companies that provide user-friendly and portable dialysis equipment stand to capture a significant market share.

By addressing the growing demand for home-based healthcare solutions, the dialysis market can attract a broader customer base and foster long-term patient satisfaction, contributing to overall market growth.

Request a sample here: https://www.nextmsc.com/us-dialysis-market/request-sample

According to the report, leading players in the U.S. dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.

Key Insights from the U.S. Dialysis Market Report:

• The information related to key drivers, restraints, and opportunities and their impact on the U.S. dialysis market is provided in the report.

• The value chain analysis in the market study provides a clear picture of the roles of each stakeholder.

• The market share of the U.S. dialysis market and their competitive analysis are provided in the report.

Share this post?